Skip to content
NKTX·Nasdaq·US

Nkarta

Nkarta is a clinical-stage biotechnology company focused on developing engineered natural killer cell therapies for cancer and other serious diseases. Its business centers on advancing proprietary cell-therapy programs and collaborating with partners to develop and commercialize these treatments.

Thematic Position

Relationship Groups

Partners1
Licensing2
Competitors29

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

5 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

government rightscompulsory licensing
U.S. government Bayh-Dole march-in rights over licensed patents
SEC 10-QAug 10, 2026

The full regulatory passage is part of the Pro plan.

13 more · Regulatory and geopolitical insights are part of the Pro plan.